Relationship between angiotensin-converting enzyme insertion/deletion polymorphism and the risk of COVID-19: a meta-analysis

H Luoyi, P Yan, F Qihong - Journal of the Renin-Angiotensin …, 2023 - journals.sagepub.com
Introduction. Research shows the correlation between angiotensin-converting enzyme
(ACE) deletion and insertion (D/I) polymorphism and COVID-19 risk; yet, conclusive …

Angiotensin‐converting‐enzyme insertion/deletion polymorphism, ACE activity, and COVID‐19: A rather controversial hypothesis. A case‐control study

A Papadopoulou, PC Fragkou… - Journal of Medical …, 2022 - Wiley Online Library
Accumulating data has shown a contribution of the renin‐angiotensin system in COVID‐19
pathogenesis. The role of angiotensin‐converting enzyme (ACE) insertion (I)/deletion (D) …

Angiotensin-converting enzyme-1 gene insertion/deletion polymorphism may be associated with COVID-19 clinical severity: a prospective cohort study

O Gunal, O Sezer, GU Ustun, CE Ozturk… - Annals of Saudi …, 2021 - annsaudimed.net
BACKGROUND: Angiotensin-converting enzyme (ACE) insertion/deletion (I/D)
polymorphism may play a role in the pathogenesis of coronavirus-19 disease (COVID-19) …

[HTML][HTML] The role of angiotensin converting enzyme 1 insertion/deletion genetic polymorphism in the risk and severity of COVID-19 infection

H Saad, K Jabotian, C Sakr, R Mahfouz, IB Akl… - Frontiers in …, 2021 - frontiersin.org
Background: Individuals infected with the COVID-19 virus present with different symptoms of
varying severity. In addition, not all individuals are infected despite exposure. Risk factors …

The role of angiotensin I converting enzyme insertion/deletion polymorphism in the severity and outcomes of COVID-19 patients

M Rezaei, H Mohammadpour, M Eftekhari… - Frontiers in …, 2022 - frontiersin.org
The pandemic of coronavirus disease in 2019 has led to a global crisis. COVID-19 shows
distinct clinical manifestations of the severity of symptoms. Numerous patients with no …

Strong association of angiotensin converting enzyme-2 gene insertion/deletion polymorphism with susceptibility to SARS-CoV-2, hypertension, coronary artery …

MM Mir, R Mir, MAA Alghamdi, BA Alsayed… - Journal of personalized …, 2021 - mdpi.com
Background: The ongoing outbreak of SARS-CoV-2 represents a significant challenge to
international health. Several reports have highlighted the importance of ACE2 on the …

Ethnic prevalence of angiotensin-converting enzyme deletion (D) polymorphism and COVID-19 risk: rationale for use of angiotensin-converting enzyme inhibitors …

R Sarangarajan, R Winn, MA Kiebish… - Journal of Racial and …, 2021 - Springer
Rationale Hypertension, obesity and diabetes are major risk factors associated with
morbidities underlying COVID-19 infections. Regression analysis correlated presence of …

[PDF][PDF] The host's angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections

JR Delanghe, MM Speeckaert, ML De Buyzere - Clin Chim Acta, 2020 - academia.edu
The outbreak of the COVID-19 pandemia in 2019/2020 has stimulated research on clinical
laboratory findings in this condition, as evidenced by two recent papers in this journal [1, 2] …

Strong association between angiotensin-converting enzyme gene InDel polymorphism and COVID-19 diseases

H Çobanogullari, EU Evren, H Evren, K Suer… - Medicina Clínica, 2023 - Elsevier
Abstract Background and Objectives The COVID-19 pandemic that emerged in China in late
2019 and spread rapidly around the world. There is evidence that COVID-19 infection can …

Single nucleotide variants (SNVs) of Angiotensin-Converting enzymes (ACE1 and ACE2): a plausible explanation for the global variation in COVID-19 prevalence

SM Atiku, D Kasozi, K Campbell - Journal of the Renin …, 2023 - journals.sagepub.com
Background. Although it is common knowledge that the coronavirus disease of 2019 (COVID-
19) and other viral infections have an uneven impact globally, the reasons for this are still …